What is the current Vaccine Syringes market size?

The current Vaccine Syringes market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the Vaccine Syringes market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Vaccine Syringes market?

Key drivers include rising vaccination rates, technological advancements, and government initiatives to improve healthcare infrastructure.

What challenges does the Vaccine Syringes market face?

Challenges include high production costs, supply chain disruptions, and stringent regulatory requirements.

Which regions are the leaders in the Vaccine Syringes market?

North America and Europe are the leading regions, accounting for over 60% of the global market share.

Who are the top companies in the Vaccine Syringes market?

Top companies include Becton Dickinson, Terumo, and Medtronic, which offer a wide range of vaccine syringes and related products.

What future opportunities exist in the Vaccine Syringes market?

Future opportunities include the development of smart syringes, increasing demand from emerging markets, and growing use in veterinary care.

How will technology impact the Vaccine Syringes market?

Technological advancements, such as auto-disable syringes, will drive growth and improve safety and efficiency in the market.

What is the current regulatory landscape for the Vaccine Syringes market?

The regulatory landscape is complex, with strict guidelines from agencies such as the FDA and WHO, ensuring safety and efficacy of vaccine syringes.

What is the future outlook for the Vaccine Syringes market?

The future outlook is positive, with increasing demand for vaccination and growing awareness of the importance of safe and effective vaccine delivery.

Vaccine Syringes Market Outlook, Trends & Forecast 2033

Vaccine Syringes by Application (Hospitals, Clinics, Community Service Center), by Types (With Needles, Needleless), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 11.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 11.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Vaccine Syringes Market Size | CAGR 11.8 Forecast 2033

Vaccine Syringes Market Outlook, Trends & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 11.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 11.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Vaccine Syringes Market Overview

The Vaccine Syringes market is a crucial segment of the medical devices industry, playing a vital role in the administration of vaccines worldwide. As the global healthcare landscape continues to evolve, the Vaccine Syringes market size is estimated to be around $1.4 billion in 2025. The growth outlook for the Vaccine Syringes market appears promising, with a market forecast indicating a steady expansion over the forecast period of 2026-2033. This industry expansion is driven by increasing vaccination programs, technological advancements, and rising demand for safety syringes. The scope of the Vaccine Syringes market encompasses various types of syringes, including disposable and reusable syringes, and applications across different end-users, such as hospitals, clinics, and vaccination centers.

Loading chart…

The Vaccine Syringes market is expected to grow at a CAGR of around 8% during the forecast period, driven by macro drivers such as increasing vaccination programs, technological advancements, and rising demand for safety syringes. Key forces shaping the industry include technology shifts towards more advanced and safe syringes, regulations promoting the use of safety syringes, and consumer behavior driving demand for convenient and easy-to-use syringes. The largest region for the Vaccine Syringes market is North America, while the fastest-growing region is Asia Pacific, driven by increasing healthcare expenditure and growing demand for vaccines in the region.

Report Overview

Report Attribute	Details
Market size value in 2025	8.20 million
Revenue forecast in 2033	20.01 million
Growth rate	CAGR of 11.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Gerresheimer; SCHOTT AG; Nipro Corporation; Stevanato; Baxter Healthcare; Catalent; Taisei Kako; West Pharmaceutical Services; Terumo; Jiangxi Sanxin Medtec; WEGO; Shandong Pharmaceutical Glass; Zibo Minkang; Shandong Ujoin Medical Technology; Jiangxi Hongda Medical Equipment Group; Zhejiang Kangkang Medical Equipment; Ningbo Zhengli Pharmaceutical Packaging
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Vaccine Syringes market is poised for significant growth, driven by increasing demand for vaccination and advancements in vaccine technology. The growth forecast for the Vaccine Syringes market size is expected to be substantial, with major players investing heavily in research and development to capitalize on emerging opportunities.

Growth Drivers2 items

Rising vaccination rates and government initiatives to improve public health infrastructure are driving the demand for Vaccine Syringes, contributing to the growth of the Vaccine Syringes market size

Advances in syringe design and technology, such as the development of safety syringes and auto-disable syringes, are enhancing the overall efficiency and safety of vaccination programs, supporting the growth forecast of the Vaccine Syringes market

Restraints2 items

Stringent regulations and standards for Vaccine Syringes, particularly with regards to sterilization and packaging, can limit the entry of new players in the market and hinder the growth of the Vaccine Syringes market size

Fluctuations in raw material prices and supply chain disruptions can impact the production costs and availability of Vaccine Syringes, affecting the growth forecast of the market

Opportunities2 items

The increasing demand for personalized medicine and vaccine therapies presents opportunities for companies to develop innovative and specialized Vaccine Syringes, driving the growth of the Vaccine Syringes market

Emerging markets and low-income countries offer significant opportunities for growth, as governments and healthcare organizations invest in improving vaccination infrastructure and expanding access to healthcare services, contributing to the growth forecast of the Vaccine Syringes market size

Challenges2 items

Ensuring the quality and safety of Vaccine Syringes, particularly in resource-constrained settings, remains a significant challenge for manufacturers and healthcare providers, impacting the growth of the Vaccine Syringes market

Managing the environmental impact of Vaccine Syringes, including waste disposal and sustainability, is becoming increasingly important, with companies facing pressure to adopt more eco-friendly practices and reduce their carbon footprint, affecting the growth forecast of the Vaccine Syringes market size

Market Segmentation

Loading chart…

The Vaccine Syringes segmentation by application is a crucial aspect of the market, as it helps in understanding the specific use cases and requirements of different vaccine types. The vaccine syringes market can be segmented into various applications, including influenza, COVID-19, and other vaccine applications. Each application has its unique characteristics, and the demand for vaccine syringes varies across these applications. For instance, the COVID-19 pandemic has driven the demand for vaccine syringes, and this trend is expected to continue in the future.

The types of vaccine syringes can be broadly classified into prefilled syringes and empty syringes. Prefilled syringes are pre-filled with the vaccine, and they offer convenience and ease of use. Empty syringes, on the other hand, require the vaccine to be filled manually, which can be time-consuming and may lead to errors. The market taxonomy of vaccine syringes by type is essential, as it helps in understanding the preferences of healthcare professionals and the requirements of different vaccine applications.

Vaccine Syringes Segmentation Breakdown7 items

Application

Hospitals

Clinics

Community Service Center

Types

With Needles

Needleless

Regional Insights

Loading chart…

The Vaccine Syringes market growth is anticipated to vary across regions, with Asia Pacific emerging as the largest region, accounting for approximately 40% of the global market share. This can be attributed to key drivers such as increasing adoption of vaccine syringes, government policies supporting vaccination programs, and significant investments in healthcare infrastructure. The demographics of the region, with a large and growing population, also contribute to its dominance in the Vaccine Syringes market.

In terms of regional forecast, Latin America is expected to be the fastest-growing region, driven by factors such as improving ecosystem maturity, rising demand for vaccination, and strategic partnerships between governments and vaccine manufacturers. North America and Europe are also expected to contribute significantly to the Vaccine Syringes market growth, with key drivers including advanced infrastructure, high adoption rates, and favorable policies. The Middle East & Africa region is anticipated to experience steady growth, driven by increasing investments in healthcare and expanding distribution networks.

Competitive Landscape

The Vaccine Syringes market is moderately consolidated, with a mix of global players and local companies competing on various levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Vaccine Syringes competitive landscape is characterized by high competition, with companies focusing on differentiating themselves through innovative products, strong channel presence, and cost advantages. Global players tend to dominate the market, but local companies are also gaining traction, particularly in emerging economies.

Companies in the Vaccine Syringes market are adopting various strategies to stay competitive, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization, which can erode their profitability. To differentiate themselves, companies are focusing on technology, service models, channel strength, customization, and cost advantages. The following companies are notable for their strategic focus:

BD: regional expansion

Gerresheimer: premium pricing

SCHOTT AG: innovation pipeline

Nipro Corporation: OEM tie-ups

Stevanato: local manufacturing

Baxter Healthcare: vertical integration

Key Vaccine Syringes Companies18 items

Gerresheimer

SCHOTT AG

Nipro Corporation

Stevanato

Baxter Healthcare

Catalent

Taisei Kako

West Pharmaceutical Services

Terumo

Jiangxi Sanxin Medtec

WEGO

Shandong Pharmaceutical Glass

Zibo Minkang

Shandong Ujoin Medical Technology

Jiangxi Hongda Medical Equipment Group

Zhejiang Kangkang Medical Equipment

Ningbo Zhengli Pharmaceutical Packaging

Market Ecosystem

The Vaccine Syringes ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. This ecosystem creates and captures value through the development, manufacturing, and distribution of vaccine syringes, ultimately delivering vaccines to patients. The ecosystem boundaries are defined by the interactions between these participants, influencing how value is created and captured.

Raw material suppliers — provide materials for syringe production

OEMs / manufacturers — produce vaccine syringes

Distributors / channel partners — distribute syringes to healthcare providers

End users / buyers — administer vaccines using syringes

Regulators/standards bodies — establish safety and efficacy standards

Service providers / after-sales — offer maintenance and support services

Data/analytics providers — track vaccination rates and outcomes

In the Vaccine Syringes ecosystem, control points are primarily held by regulators and standards bodies, who influence adoption through safety and efficacy standards. Dependency risks arise from input constraints, such as raw material availability, and approvals from regulatory bodies. Switching costs are relatively high due to the need for compatibility with existing vaccination systems and interoperability requirements. A thorough value chain analysis is necessary to understand these dynamics and how they differ by region, where diverse regulatory frameworks and healthcare systems shape the ecosystem.

Recent Industry Insights

The Vaccine Syringes industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key market players have focused on enhancing vaccine delivery systems, improving safety, and reducing waste. Notable mergers and acquisitions have also taken place, leading to increased consolidation and expansion of product portfolios. Furthermore, several companies have launched innovative products and technologies, such as prefilled syringes and needle-free injection systems, to cater to the growing demand for efficient and safe vaccine administration. Regulatory changes, including updated guidelines for syringe design and manufacturing, have also impacted the industry. Additionally, there has been a shift in consumer and enterprise trends, with a growing emphasis on sustainability and environmental responsibility in the Vaccine Syringes industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Vaccine Syringes market outlook. The market exhibits a moderate level of attractiveness, driven by increasing demand for vaccination programs and government initiatives. The competitive intensity is relatively high, with key players focusing on innovation and quality to differentiate themselves. The long-term outlook appears positive, with growing demand for vaccine syringes in emerging markets and the ongoing development of new vaccines.

The innovation landscape is characterized by advancements in syringe design and material technology, enhancing safety and efficiency. However, the demand–supply balance may be affected by regulatory factors and supply chain disruptions. Key risk factors include raw material shortages and intense competition. Overall, the Vaccine Syringes market outlook is favorable, with opportunities for growth and innovation in the coming years.

12 items

1. Executive Summary

2. Vaccine Syringes Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Vaccine Syringes Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Vaccine Syringes Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Vaccine Syringes Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Vaccine Syringes Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Vaccine Syringes Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Vaccine Syringes Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Vaccine Syringes Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Vaccine Syringes Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Vaccine Syringes Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Vaccine Syringes Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Vaccine Syringes Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Vaccine Syringes Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Vaccine Syringes Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Vaccine Syringes Market Competition by Key Manufacturers

9.1. Global Vaccine Syringes Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Vaccine Syringes: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. BD

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Gerresheimer

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. SCHOTT AG

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Nipro Corporation

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Stevanato

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Baxter Healthcare

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Catalent

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Taisei Kako

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. West Pharmaceutical Services

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Terumo

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Jiangxi Sanxin Medtec

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. WEGO

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Shandong Pharmaceutical Glass

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Zibo Minkang

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Shandong Ujoin Medical Technology

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Jiangxi Hongda Medical Equipment Group

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Zhejiang Kangkang Medical Equipment

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Ningbo Zhengli Pharmaceutical Packaging

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Vaccine Syringes Market

Figure 4: Global Vaccine Syringes Market: Drivers

Figure 5: Global Vaccine Syringes Market: Challenges

Figure 6: Global Vaccine Syringes Market: Trends

Figure 7: Global Vaccine Syringes Market: Opportunity

Figure 8: Global Vaccine Syringes Market: Restraint

Figure 9: Global Vaccine Syringes Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Vaccine Syringes Market Value (USD Million) By Region

Figure 19: Global Vaccine Syringes Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Vaccine Syringes Market Value (USD Million) By Region

Figure 27: Global Vaccine Syringes Market Share (%) By: Regions (2032)

Figure 28: Global Vaccine Syringes Market Volume (K) By Region

Figure 29: Global Vaccine Syringes Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Vaccine Syringes Market Value (USD Million) By Region

Figure 37: Global Vaccine Syringes Market Share (%) By: Regions (2032)

Figure 38: Global Vaccine Syringes Market Volume (K) By Region

Figure 39: Global Vaccine Syringes Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

131 items

Table 1: Market Segmentation Analysis

Table 2: Global Vaccine Syringes Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Vaccine Syringes Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Vaccine Syringes Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Vaccine Syringes Market Value (USD Million) By Region

Table 14: Global Vaccine Syringes Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Vaccine Syringes Market Volume (K) By Region

Table 31: Global Vaccine Syringes Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Vaccine Syringes Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Vaccine Syringes Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Vaccine Syringes Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: BD Basic Information And Sales Area

Table 52: BD. Products Portfolio

Table 53: Gerresheimer Basic Information And Sales Area

Table 54: Gerresheimer. Products Portfolio

Table 55: SCHOTT AG Basic Information And Sales Area

Table 56: SCHOTT AG. Products Portfolio

Table 57: Nipro Corporation Basic Information And Sales Area

Table 58: Nipro Corporation. Products Portfolio

Table 59: Stevanato Basic Information And Sales Area

Table 60: Stevanato. Products Portfolio

Table 61: Baxter Healthcare Basic Information And Sales Area

Table 62: Baxter Healthcare. Products Portfolio

Table 63: Catalent Basic Information And Sales Area

Table 64: Catalent. Products Portfolio

Table 65: Taisei Kako Basic Information And Sales Area

Table 66: Taisei Kako. Products Portfolio

Table 67: West Pharmaceutical Services Basic Information And Sales Area

Table 68: West Pharmaceutical Services. Products Portfolio

Table 69: Terumo Basic Information And Sales Area

Table 70: Terumo. Products Portfolio

Table 71: Jiangxi Sanxin Medtec Basic Information And Sales Area

Table 72: Jiangxi Sanxin Medtec. Products Portfolio

Table 73: WEGO Basic Information And Sales Area

Table 74: WEGO. Products Portfolio

Table 75: Shandong Pharmaceutical Glass Basic Information And Sales Area

Table 76: Shandong Pharmaceutical Glass. Products Portfolio

Table 77: Zibo Minkang Basic Information And Sales Area

Table 78: Zibo Minkang. Products Portfolio

Table 79: Shandong Ujoin Medical Technology Basic Information And Sales Area

Table 80: Shandong Ujoin Medical Technology. Products Portfolio

Table 81: Jiangxi Hongda Medical Equipment Group Basic Information And Sales Area

Table 82: Jiangxi Hongda Medical Equipment Group. Products Portfolio

Table 83: Zhejiang Kangkang Medical Equipment Basic Information And Sales Area

Table 84: Zhejiang Kangkang Medical Equipment. Products Portfolio

Table 85: Ningbo Zhengli Pharmaceutical Packaging Basic Information And Sales Area

Table 86: Ningbo Zhengli Pharmaceutical Packaging. Products Portfolio

Table 87: Global Market Value (USD Million) (2025-2032) By Application

Table 88: Global Market Share (%) By Application (2032)

Table 89: Global Market Value (USD Million) (2025-2032) By Types

Table 90: Global Market Share (%) By Types (2032)

Table 91: Global Market Volume (K) (2025-2032) By Application

Table 92: Global Market Share (%) By Application (2032)

Table 93: Global Market Volume (K) (2025-2032) By Types

Table 94: Global Market Share (%) By Types (2032)

Table 95: Global Vaccine Syringes Market Value (USD Million) By Region

Table 96: Global Vaccine Syringes Market Share (%) By Region (2025-2032)

Table 97: North America Market Value (USD Million) (2025-2032) By Country

Table 98: North America Market Value (USD Million) (2025-2032) By Application

Table 99: North America Market Value (USD Million) (2025-2032) By Types

Table 100: Europe Market Value (USD Million) (2025-2032) By Country

Table 101: Europe Market Value (USD Million) (2025-2032) By Application

Table 102: Europe Market Value (USD Million) (2025-2032) By Types

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 104: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 105: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 106: South America Market Value (USD Million) (2025-2032) By Country

Table 107: South America Market Value (USD Million) (2025-2032) By Application

Table 108: South America Market Value (USD Million) (2025-2032) By Types

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 110: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 111: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 112: Global Vaccine Syringes Market Volume (K) By Region

Table 113: Global Vaccine Syringes Market Share (%) By Region (2025-2032)

Table 114: North America Market Volume (K) (2025-2032) By Country

Table 115: North America Market Volume (K) (2025-2032) By Application

Table 116: North America Market Volume (K) (2025-2032) By Types

Table 117: Europe Market Volume (K) (2025-2032) By Country

Table 118: Europe Market Volume (K) (2025-2032) By Application

Table 119: Europe Market Volume (K) (2025-2032) By Types

Table 120: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 121: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 122: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 123: South America Market Volume (K) (2025-2032) By Country

Table 124: South America Market Volume (K) (2025-2032) By Application

Table 125: South America Market Volume (K) (2025-2032) By Types

Table 126: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 127: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 128: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 129: Research Programs/Design For This Report

Table 130: Key Data Information From Secondary Sources

Table 131: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Vaccine Syringes Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.20 million
Revenue forecast in 2033	20.01 million
Growth rate	CAGR of 11.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Gerresheimer; SCHOTT AG; Nipro Corporation; Stevanato; Baxter Healthcare; Catalent; Taisei Kako; West Pharmaceutical Services; Terumo; Jiangxi Sanxin Medtec; WEGO; Shandong Pharmaceutical Glass; Zibo Minkang; Shandong Ujoin Medical Technology; Jiangxi Hongda Medical Equipment Group; Zhejiang Kangkang Medical Equipment; Ningbo Zhengli Pharmaceutical Packaging
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options